Based upon the subgroup Examination, we discovered that there was important heterogeneity in terms of mortality, favorable results, and the entire therapy effective fee. Regarding mortality, The explanation for heterogeneity on the subgroup of edaravone dexborneol and EDV was mostly attributed to distinctions in drug dosage. Concerning favorable outcomes, The https://neuroprotectives-for-sale07787.jts-blog.com/32318972/little-known-facts-about-what-are-the-best-neuroprotective-drugs